4//SEC Filing
Goldman Leslie J. 4
Accession 0001104659-20-080812
CIK 0001072379other
Filed
Jul 1, 8:00 PM ET
Accepted
Jul 2, 9:55 PM ET
Size
8.1 KB
Accession
0001104659-20-080812
Insider Transaction Report
Form 4
Goldman Leslie J.
Senior Vice President
Transactions
- Award
Options to purchase Common Stock, par value $0.001
2020-07-02+5,415,952→ 5,415,952 totalExercise: $0.21From: 2020-07-02Exp: 2030-07-02→ Common Stock, par value $0.001 (5,415,952 underlying) - Award
Options to purchase Common Stock, par value $0.001
2020-07-02+1,315,566→ 1,315,566 totalExercise: $0.25From: 2020-07-02Exp: 2030-07-02→ Common Stock, par value $0.001 (1,315,566 underlying)
Footnotes (2)
- [F1]These options were already approved and publicly reported in 2018. The exercise price was determined with reference to the pricing for unrelated investors at that time. However, the documents to implement and issue (grant) them have not been executed until now.
- [F2]These options were approved in January 2020. The exercise price was determined based upon the pricing in year-end financings with unrelated investors. However, these options have not been executed and implemented (granted) until now.
Documents
Issuer
NORTHWEST BIOTHERAPEUTICS INC
CIK 0001072379
Entity typeother
Related Parties
1- filerCIK 0001742619
Filing Metadata
- Form type
- 4
- Filed
- Jul 1, 8:00 PM ET
- Accepted
- Jul 2, 9:55 PM ET
- Size
- 8.1 KB